OS Therapies Inc financial data

Symbol
OSTX on NYSE
Location
15825 Shady Grove Road, Suite 135, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 6.26 %
Debt-to-equity -107 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.2M shares
Common Stock, Shares, Outstanding 21.2M shares
Common Stock, Value, Issued 21.2K USD
Weighted Average Number of Shares Outstanding, Basic 15.9M shares +198%
Weighted Average Number of Shares Outstanding, Diluted 15.9M shares +198%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.21M USD +166%
General and Administrative Expense 1.23M USD +632%
Operating Income (Loss) -2.44M USD -292%
Nonoperating Income (Expense) -438K USD +67.6%
Net Income (Loss) Attributable to Parent -2.88M USD -45.6%
Earnings Per Share, Basic -0.18 USD/shares +52.6%
Earnings Per Share, Diluted -0.18 USD/shares +52.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 1.97M USD
Property, Plant and Equipment, Net 6.66K USD
Assets 1.98M USD
Accounts Payable, Current 1.77M USD
Accrued Liabilities, Current 296K USD
Liabilities, Current 2.58M USD
Liabilities 2.68M USD
Retained Earnings (Accumulated Deficit) -35.4M USD
Stockholders' Equity Attributable to Parent -707K USD +96.9%
Liabilities and Equity 1.98M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -642K USD -49.9%
Net Cash Provided by (Used in) Financing Activities 703K USD +15.1%
Common Stock, Shares Authorized 50M shares
Common Stock, Shares, Issued 21.2M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.86M USD +11470%
Depreciation 695 USD +595%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Additional Paid in Capital 34.7M USD
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 829K USD +3.73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares